-
Temporal production of the signaling lipid phosphatidic acid by phospholipase D2 determines the output of extracellular signal-regulated kinase signaling in cancer cells.
Mol Cell Biol. 2014 Jan;34(1):84-95
PMID: 24164897
-
DEPTOR cell-autonomously promotes adipogenesis, and its expression is associated with obesity.
Cell Metab. 2012 Aug 8;16(2):202-12
PMID: 22883231
-
Phospholipase D and the maintenance of phosphatidic acid levels for regulation of mammalian target of rapamycin (mTOR).
J Biol Chem. 2014 Aug 15;289(33):22583-8
PMID: 24990952
-
Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB.
Mol Cell. 2006 Apr 21;22(2):159-68
PMID: 16603397
-
Phosphatidic acid-mediated mitogenic activation of mTOR signaling.
Science. 2001 Nov 30;294(5548):1942-5
PMID: 11729323
-
Phospholipase D1b and D2a generate structurally identical phosphatidic acid species in mammalian cells.
Biochem J. 2001 Dec 15;360(Pt 3):707-15
PMID: 11736663
-
PLD1 regulates mTOR signaling and mediates Cdc42 activation of S6K1.
Curr Biol. 2003 Dec 2;13(23):2037-44
PMID: 14653992
-
Role of phospholipase D1 in the regulation of mTOR activity by lysophosphatidic acid.
FASEB J. 2004 Feb;18(2):311-9
PMID: 14769825
-
Phosphatidic acid that accumulates in platelet-derived growth factor-stimulated Balb/c 3T3 cells is a potential mitogenic signal.
J Biol Chem. 1992 Jun 5;267(16):10988-93
PMID: 1597441
-
Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases.
Cell. 1992 Jun 26;69(7):1227-36
PMID: 1377606
-
Regulation of interleukin-2 responses by phosphatidic acid.
Eur J Immunol. 1992 Jul;22(7):1883-9
PMID: 1623928
-
Structure of the FKBP12-rapamycin complex interacting with the binding domain of human FRAP.
Science. 1996 Jul 12;273(5272):239-42
PMID: 8662507
-
The FKBP12-rapamycin-binding domain is required for FKBP12-rapamycin-associated protein kinase activity and G1 progression.
J Biol Chem. 1999 Feb 12;274(7):4266-72
PMID: 9933627
-
Modulation of the mammalian target of rapamycin pathway by diacylglycerol kinase-produced phosphatidic acid.
J Biol Chem. 2005 Mar 18;280(11):10091-9
PMID: 15632115
-
Phospholipase D: a lipid centric review.
Cell Mol Life Sci. 2005 Oct;62(19-20):2305-16
PMID: 16143829
-
Substrate specificity of lysophosphatidic acid acyltransferase beta -- evidence from membrane and whole cell assays.
J Lipid Res. 2006 Mar;47(3):593-604
PMID: 16369050
-
The FRB domain of mTOR: NMR solution structure and inhibitor design.
Biochemistry. 2006 Aug 29;45(34):10294-302
PMID: 16922504
-
Identification of a novel human lysophosphatidic acid acyltransferase, LPAAT-theta, which activates mTOR pathway.
J Biochem Mol Biol. 2006 Sep 30;39(5):626-35
PMID: 17002884
-
Defining the role of mTOR in cancer.
Cancer Cell. 2007 Jul;12(1):9-22
PMID: 17613433
-
Structural characterization of the interaction of mTOR with phosphatidic acid and a novel class of inhibitor: compelling evidence for a central role of the FRB domain in small molecule-mediated regulation of mTOR.
Oncogene. 2008 Jan 24;27(5):585-95
PMID: 17684489
-
The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1.
Science. 2008 Jun 13;320(5882):1496-501
PMID: 18497260
-
Phospholipase D1 is an effector of Rheb in the mTOR pathway.
Proc Natl Acad Sci U S A. 2008 Jun 17;105(24):8286-91
PMID: 18550814
-
Syndecan-4 regulates subcellular localization of mTOR Complex2 and Akt activation in a PKCalpha-dependent manner in endothelial cells.
Mol Cell. 2008 Oct 10;32(1):140-9
PMID: 18851840
-
Molecular mechanisms of mTOR-mediated translational control.
Nat Rev Mol Cell Biol. 2009 May;10(5):307-18
PMID: 19339977
-
Functional characterization of the human 1-acylglycerol-3-phosphate-O-acyltransferase isoform 10/glycerol-3-phosphate acyltransferase isoform 3.
J Mol Endocrinol. 2009 Jun;42(6):469-78
PMID: 19318427
-
Biochemistry, physiology, and genetics of GPAT, AGPAT, and lipin enzymes in triglyceride synthesis.
Am J Physiol Endocrinol Metab. 2009 Jun;296(6):E1195-209
PMID: 19336658
-
DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival.
Cell. 2009 May 29;137(5):873-86
PMID: 19446321
-
Mammalian diacylglycerol kinases: molecular interactions and biological functions of selected isoforms.
Biochim Biophys Acta. 2009 Jun;1790(6):416-24
PMID: 19364481
-
Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids.
Cell. 2010 Apr 16;141(2):290-303
PMID: 20381137
-
mTOR complex 2 signaling and functions.
Cell Cycle. 2011 Jul 15;10(14):2305-16
PMID: 21670596
-
Phosphatidic acid activates mammalian target of rapamycin complex 1 (mTORC1) kinase by displacing FK506 binding protein 38 (FKBP38) and exerting an allosteric effect.
J Biol Chem. 2011 Aug 26;286(34):29568-74
PMID: 21737445
-
Endoplasmic reticulum is a main localization site of mTORC2.
Biochem Biophys Res Commun. 2011 Sep 16;413(1):46-52
PMID: 21867682
-
mTOR drives its own activation via SCF(βTrCP)-dependent degradation of the mTOR inhibitor DEPTOR.
Mol Cell. 2011 Oct 21;44(2):290-303
PMID: 22017875
-
DEPTOR, an mTOR inhibitor, is a physiological substrate of SCF(βTrCP) E3 ubiquitin ligase and regulates survival and autophagy.
Mol Cell. 2011 Oct 21;44(2):304-16
PMID: 22017876
-
mTOR generates an auto-amplification loop by triggering the βTrCP- and CK1α-dependent degradation of DEPTOR.
Mol Cell. 2011 Oct 21;44(2):317-24
PMID: 22017877
-
Class III PI-3-kinase activates phospholipase D in an amino acid-sensing mTORC1 pathway.
J Cell Biol. 2011 Oct 31;195(3):435-47
PMID: 22024166
-
Glycerolipid signals alter mTOR complex 2 (mTORC2) to diminish insulin signaling.
Proc Natl Acad Sci U S A. 2012 Jan 31;109(5):1667-72
PMID: 22307628
-
mTOR signaling in growth control and disease.
Cell. 2012 Apr 13;149(2):274-93
PMID: 22500797
-
A protease for 'middle-down' proteomics.
Nat Methods. 2012 Aug;9(8):822-4
PMID: 22706673
-
Spatial control of the TSC complex integrates insulin and nutrient regulation of mTORC1 at the lysosome.
Cell. 2014 Feb 13;156(4):771-85
PMID: 24529379